Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits

Directors Byron Pickard, Trey Powers, Chandrika Vira, William Milliken, Anna Phillips, and Tyler Dutton were mentioned as representing TwinStrand Biosciences in the Mealey’s article “Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits.” The following is an excerpt from the article:

“Jurors empaneled in Delaware federal court delivered a win to the owner and exclusive licensee of two cancer-detection patents, deeming the technology willfully infringed by Guardant Health Inc.

The University of Washington and TwinStrand Biosciences Inc. (TwinStrand, collectively) on Nov. 14 were awarded $83.4 million by the jury, representing a 6% royalty on Guardant’s $1.39 billion royalty base.”

To read the full article, please click the “Download PDF” button.